INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-18-00165

Multiple treatment approaches following incomplete endovascular closure of abdominal aneurysm rupture-related aortocaval fistula

Alexander Massmann*, MD; Peter Fries, MD; Reinhard Kubale, MD; Roland Seidel, MD

Aortocaval fistula (ACF) as a result of abdominal aortic aneurysm (AAA) rupture is very rare, and associated morbidity and mortality are very high. Open surgical and endovascular treatment, even combined as a hybrid procedure, is also associated with high complication rates. Surgical approaches include ACF ligature and aneurysm resection. An endovascular approach by aortic endograft deployment (endovascular aneurysm repair [EVAR]) may result in acute right heart failure or insufficient AAA and ACF coverage. We present a staged approach for percutaneous ACF treatment by escalating endovascular means.

A 59-year-old patient presented with signs of congestive heart failure and abdominal pain. Auscultation revealed loud periumbilical continuous machine-type bruits with systolic accentuation. Ultrasound depicted volume overload-related right heart insufficiency combined with consecutive congestion-induced liver cirrhosis. Contrast-enhanced computed tomography (CT) showed an underlying AAA (diameter 7.5 cm) associated with a large ACF to the infrarenal vena cava (IVC).

After urgent EVAR (Aorfix™ Endovascular Stent Graft; Lombard Medical, Didcot, United Kingdom), based on an interdisciplinary decision, a large endoleak type 2 (EL2) was obvious and ACF persisted (Moving image 1). Two weeks later, the inferior mesenteric artery was embolised using coils (Nester® Embolization Coil, 0.035”; Cook Medical, Bloomington, IN, USA).

Percutaneous CT-guided glue embolisation (Glubran®2; GEM Srl, Viareggio, Italy) of multiple lumbar arteries potentially feeding the ACF was aborted, because persistent high flow prevented ACF occlusion, resulting in asymptomatic minor pulmonary embolism.

Considerable flow reduction was achieved by transjugular cannulation (Moving image 2) and deployment of a large vascular plug (Pillow AAA Occlusion Device, 25/80 mm, 9 Fr; AndraTec GmbH, Koblenz, Germany) into the aneurysm sac (Panel A-Panel C, Moving image 3). The occluder used was a clinical investigational device. The procedure was performed after informed consent was obtained from the patient. Direct coverage of ACF was achieved by transjugular off-label venous stenting of the IVC (Ovation® Abdominal Stent Graft Platform, iliac extension EX22-22-45; Endologix Inc., Irvine, CA, USA) (Panel D, Panel E, Moving image 4).

Seven months later, persisting EL2 and low-flow ACF (Moving image 5) was treated by CT-guided percutaneous coil embolisation of the aneurysm and lumbar arteries. Coil dislocation into the IVC via the ACF (Panel F) necessitated immediate endovascular transvenous coil retrieval and repositioning (Moving image 6), which was combined with additional coil embolisation of the ACF (22x Ruby® Penumbra Occlusion Device [POD®] detachable coils; Penumbra Inc., Alameda, CA, USA) (Panel G).

Finally, EL2 and ACF were successfully treated by percutaneous glue embolisation of the median sacral artery four months later (Panel H).

Follow-up after another six months showed a completely recovered and asymptomatic patient. Contrast-enhanced ultrasound and CT (Moving image 7) confirmed successful closure of the ACF, EL, AAA shrinkage and improvement of right heart insufficiency with decreasing liver stiffness indicating remodelling. Initial NT-proBNP (383.1 pg/ml) and elastography (2.53 m/s) normalised.

Generally, EVAR aims at instant aneurysm exclusion. In our case, stepwise flow reduction of the ACF was necessary, yielding successive reduction of right heart stress.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Coronal view of contrast-enhanced computed tomography depicts a persisting large aortocaval fistula post EVAR using Lombard’s Aorfix stent graft system.

Moving image 2. Fluoroscopy shows transjugular direct cannulation of the aortocaval fistula with a 4 Fr cobra catheter. The Aorfix stent graft is identified by the typical ring design and its fishmouth-like stent graft endings. Partial opacification of the aneurysm sac results from Lipiodol-mixed glue. The inferior mesenteric artery is occluded by coil embolisation.

Moving image 3. Transjugular deployment of a large vascular occluder (Pillow AAA Occlusion Devicee 25/80 mm) into the aortic aneurysm sac for coverage of the aortocaval fistula.

Moving image 4. Transjugular venous deployment of an aortic stent graft into the inferior vena cava for direct coverage of the aortocaval fistula (Ovation iliac extension EX22-22-45 mm). Transfemoral access was avoided to minimise the risk of infection after previous EVAR.

Moving image 5. Contrast-enhanced ultrasound shows the bifurcated aortic stent graft (Aorfix) and vascular occlusion device (Pillow AAA Occlusion Device). After injection of 1.2 ml SonoVue® (Bracco Imaging, Milan, Italy) persistence of a large endoleak type 2 and aortocaval fistula is proven by intense opacification of the inferior vena cava by contrast bubbles.

Moving image 6. Transvenous repositioning of a coil, which was inserted via percutaneous access to the abdominal aortic aneurysm and dislocated via the patent aortocaval fistula into the inferior vena cava.

Moving image 7. Transvenous repositioning of a coil, which was inserted via percutaneous access to the abdominal aortic aneurysm and dislocated via the patent aortocaval fistula into the inferior vena cava.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Coronal view of contrast-enhanced computed tomography depicts a persisting large aortocaval fistula post EVAR using Lombard’s Aorfix stent graft system.

Moving image 2. Fluoroscopy shows transjugular direct cannulation of the aortocaval fistula with a 4 Fr cobra catheter. The Aorfix stent graft is identified by the typical ring design and its fishmouthlike stent graft endings. Partial opacification of the aneurysm sac results from Lipiodol-mixed glue. The inferior mesenteric artery is occluded by coil embolisation.

Moving image 3. Transjugular deployment of a large vascular occluder (Pillow AAA Occlusion Devicee 25/80 mm) into the aortic aneurysm sac for coverage of the aortocaval fistula.

Moving image 4. Transjugular venous deployment of an aortic stent graft into the inferior vena cava for direct coverage of the aortocaval fistula (Ovation iliac extension EX22-22-45 mm).Transfemoral access was avoided to minimise the risk of infection after previous EVAR.

Moving image 5. Contrast-enhanced ultrasound shows the bifurcated aortic stent graft (Aorfix) and vascular occlusion device (Pillow AAA Occlusion Device). After injection of 1.2 ml SonoVue® (Bracco Imaging, Milan, Italy) persistence of a large endoleak type 2 and aortocaval fistula is proven by intense opacification of the inferior vena cava by contrast bubbles.

Moving image 6. Transvenous repositioning of a coil, which was inserted via percutaneous access to the abdominal aortic aneurysm and dislocated via the patent aortocaval fistula into the inferior vena cava.

Moving image 7. Transvenous repositioning of a coil, which was inserted via percutaneous access to the abdominal aortic aneurysm and dislocated via the patent aortocaval fistula into the inferior vena cava.

Volume 14 Number 7
Sep 20, 2018
Volume 14 Number 7
View full issue


Key metrics

On the same subject

Image – Interventional flashlight

10.4244/EIJ-D-19-00198 Jun 12, 2020
Percutaneous closure of atrial fistula after ascending aortic aneurysm surgery using cardiac fusion imaging
Cruz-González I et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV12I8A165 Oct 10, 2016
Percutaneous closure of an iatrogenic aortocoronary venous fistula after coronary bypass graft surgery
Sandhu K et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV12I9A193 Oct 20, 2016
Large left lung mass: an unexpected finding
Henzel J et al
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00253 Oct 11, 2017
Successful percutaneous aspiration and endovascular stenting of a symptomatic floating thrombus located in the distal aortic arch
Deichstetter M et al
free

Clinical research

10.4244/EIJ-D-19-00547 Apr 2, 2021
Endovascular aortic repair in patients with challenging anatomies: the EXTREME study
Sirignano P et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00294 Dec 20, 2018
Safety and efficacy of percutaneous closure of ruptured sinus of Valsalva aneurysm
Yang K et al
free
Trending articles
281.53

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved